BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 21103974)

  • 1. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D
    Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs.
    Yu XQ; Xue CC; Wang G; Zhou SF
    Curr Drug Metab; 2007 Dec; 8(8):787-802. PubMed ID: 18220559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
    Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate.
    Homolya L; Váradi A; Sarkadi B
    Biofactors; 2003; 17(1-4):103-14. PubMed ID: 12897433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian multidrug-resistance proteins (MRPs).
    Slot AJ; Molinski SV; Cole SP
    Essays Biochem; 2011 Sep; 50(1):179-207. PubMed ID: 21967058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic secretion of conjugated drugs and endogenous substances.
    Keppler D; König J
    Semin Liver Dis; 2000; 20(3):265-72. PubMed ID: 11076395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.
    König J; Nies AT; Cui Y; Leier I; Keppler D
    Biochim Biophys Acta; 1999 Dec; 1461(2):377-94. PubMed ID: 10581368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
    Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion.
    Keppler D; Leier I; Jedlitschky G; Mayer R; Büchler M
    Adv Enzyme Regul; 1996; 36():17-29. PubMed ID: 8869738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated proteins and implications in drug development.
    Liu YH; Di YM; Zhou ZW; Mo SL; Zhou SF
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):115-20. PubMed ID: 19566819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A family of drug transporters: the multidrug resistance-associated proteins.
    Borst P; Evers R; Kool M; Wijnholds J
    J Natl Cancer Inst; 2000 Aug; 92(16):1295-302. PubMed ID: 10944550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.
    König J; Rost D; Cui Y; Keppler D
    Hepatology; 1999 Apr; 29(4):1156-63. PubMed ID: 10094960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.
    Nies AT; Jedlitschky G; König J; Herold-Mende C; Steiner HH; Schmitt HP; Keppler D
    Neuroscience; 2004; 129(2):349-60. PubMed ID: 15501592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of leukotriene C4 and structurally related conjugates.
    Jedlitschky G; Keppler D
    Vitam Horm; 2002; 64():153-84. PubMed ID: 11898391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRP subfamily transporters and resistance to anticancer agents.
    Kruh GD; Zeng H; Rea PA; Liu G; Chen ZS; Lee K; Belinsky MG
    J Bioenerg Biomembr; 2001 Dec; 33(6):493-501. PubMed ID: 11804191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.
    Chen ZS; Tiwari AK
    FEBS J; 2011 Sep; 278(18):3226-45. PubMed ID: 21740521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes.
    Roggenbeck BA; Carew MW; Charrois GJ; Douglas DN; Kneteman NM; Lu X; Le XC; Leslie EM
    Toxicol Sci; 2015 Jun; 145(2):307-20. PubMed ID: 25752797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates.
    Koenderink JB; van den Heuvel JJMW; Bilos A; Vredenburg G; Vermeulen NPE; Russel FGM
    Arch Toxicol; 2020 Sep; 94(9):3027-3032. PubMed ID: 32472168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.